These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 13148498)

  • 21. [Hydantoin therapy of petit mal attacks in children].
    SCHMUTTERMEIER E
    Monatsschr Kinderheilkd (1902); 1954 Feb; 102(2):69-70. PubMed ID: 13165434
    [No Abstract]   [Full Text] [Related]  

  • 22. Mesantoin in the treatment of convulsive disorders.
    LITTLJOHN WS; LITTLE SC; McLALLEN CD
    Dis Nerv Syst; 1951 Sep; 12(9):269-73. PubMed ID: 14887566
    [No Abstract]   [Full Text] [Related]  

  • 23. THE TREATMENT OF EPILEPSY WITH METHYLPHENYLETHYL HYDANTOIN (MESANTOIN).
    Aird RB
    Calif Med; 1948 Mar; 68(3):141-6. PubMed ID: 18731395
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical experiences with a new anti-epileptic drug: hydotin (3-methyl-5,5-diphenyl-hydantoin)].
    CASTELLUCCIO R
    Sem Med; 1952 Apr; 100(14):405-8. PubMed ID: 14942571
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hydantoin therapy in epilepsy].
    STRAUCH W
    Dtsch Gesundheitsw; 1953 May; 8(20):591-601. PubMed ID: 13067813
    [No Abstract]   [Full Text] [Related]  

  • 26. Ethotoin (peganone), a new anticonvulsant.
    ZIMMERMAN FT; BURGEMEISTER BB
    N Y State J Med; 1958 Jun; 58(12):2054-6. PubMed ID: 13553007
    [No Abstract]   [Full Text] [Related]  

  • 27. N-methylated derivatives of barbituric acid, hydantoin and oxazolidinedione used in the treatment of epilepsy.
    BUTLER TC; WADDELL WJ
    Neurology; 1958 Apr; 8(Suppl 1):106-12. PubMed ID: 13541627
    [No Abstract]   [Full Text] [Related]  

  • 28. ANTICONVULSANT drugs in epilepsy.
    Med World; 1952 Jul; 76(18):489. PubMed ID: 14947377
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical evaluation of peganone, a new anticonvulsant.
    CARTER CH; MALEY MC
    Am J Med Sci; 1957 Jul; 234(1):74-7; passim. PubMed ID: 13435256
    [No Abstract]   [Full Text] [Related]  

  • 30. A pharmacological comparison of the optical isomers of 5-ethyl-5-phenyl hydantoin (nirvanol) and of 3-methyl-5-ethyl-5-phenyl hydantoin (mesantoin).
    BUTLER TC; WADDELL WJ
    J Pharmacol Exp Ther; 1954 Jan; 110(1):120-5. PubMed ID: 13118486
    [No Abstract]   [Full Text] [Related]  

  • 31. Deducing the bioactive face of hydantoin anticonvulsant drugs using NMR spectroscopy.
    Tiedje KE; Weaver DF
    Can J Neurol Sci; 2008 May; 35(2):232-6. PubMed ID: 18574940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [3-Methyl-5, 5-phenylethylhydantoin therapy of epilepsy].
    DONATI A; BERNARDI L
    Rass Studi Psichiatr; 1952; 41(6):1171-92. PubMed ID: 13047632
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experiences with hydantal Sandoz and Mesantoin in the therapy of epilepsy of children].
    SCHMUTTERMEIER E; STACHEL I
    Osterr Z Kinderheilkd Kinderfuersorge; 1952 Jan; 7(1-2):133-47. PubMed ID: 14948161
    [No Abstract]   [Full Text] [Related]  

  • 34. [The value of 3-methyl 5.5. phenylethylhydantoin in therapy of epilepsy].
    HOLTZER PA
    Geneeskd Gids; 1952 May; 30(9):181-7. PubMed ID: 14955069
    [No Abstract]   [Full Text] [Related]  

  • 35. Nuvarone (3-methyl-5, phenylhydantoin) in the treatment of epilepsy.
    TATERKA JH; THOMPSON CB
    Dis Nerv Syst; 1953 Apr; 14(4):108-10. PubMed ID: 13052037
    [No Abstract]   [Full Text] [Related]  

  • 36. [Early per- and postoperative epileptic seizures during operations on osteomeningeal breaches. Value of preventive treatment with hydantoins].
    Lauxerois M; Pechadre JC; Bonnard M; Colnet G; Gibert J; Chabannes J
    Neurochirurgie; 1984; 30(4):241-4. PubMed ID: 6472546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative studies of the physiological disposition of 3-methyl-5-ethyl-5-phenyl hydantoin (mesantoin) and 5-ethyl-5-phenyl hydantoin (nirvanol).
    BUTLER TC
    J Pharmacol Exp Ther; 1953 Nov; 109(3):340-5. PubMed ID: 13109695
    [No Abstract]   [Full Text] [Related]  

  • 38. [Lupus erythematosus and epilepsy--a case following treatment with hydantoin].
    Bréaud P; Caviezel O
    Praxis; 1966 Sep; 55(39):1095-100. PubMed ID: 6013485
    [No Abstract]   [Full Text] [Related]  

  • 39. Methyl hydantoin in the treatment of epilepsy.
    DAVID NA; DURKIN LS
    J Nerv Ment Dis; 1948 Aug; 108(2):118-28. PubMed ID: 18876440
    [No Abstract]   [Full Text] [Related]  

  • 40. Fatal pancytopenia as a result of improperly supervised mesantoin therapy.
    BURRELL ZL
    Am Pract Dig Treat; 1955 May; 6(5):726-8. PubMed ID: 14361960
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.